Pfizer Covid-19 vaccine contract signatories

Date sent: 19 January 2024

OIA response

Thank you for your request dated 19 January 2024 under the Official Information Act 1982 (OIA). You requested:

PART 1:

What were the initials of the signatories to Pfizer’s Covid-19 vaccine contract in New Zealand?

What was/were the job title(s) of the signatories to Pfizer’s Covid-19 vaccine contract in New Zealand?

How many genetically female and how many genetically male signatories to Pfizer’s Covid-19 vaccine contract in New Zealand?

How many signatories to Pfizer’s Covid-19 vaccine contract in New Zealand?

PART 2:

Who were the signatories to Pfizer’s Covid-19 vaccine contract in New Zealand

I have interpreted your request for the Pfizer COVID-19 vaccine contract to be the Advance Purchase Agreement and its subsequent amendments signed between the New Zealand Government and Pfizer. The signatories, job titles, and initials are listed in the table below:

Name of signatory	Job title (at time of signing)	Initial
Grant Robertson	Minister of Finance	G.R.
Ashley Bloomfield	Director General of Health	A.B.
Robyn Shearer	Acting Director General of Health	R.S.
Sarah Turner	Acting Director General of Health	S.T.
Peter Alsop	Acting Chief Executive, Pharmac	P.A.
Peter Bramley	Interim Chair, Pharmac	P.B.
Sarah Fitt	Chief Executive, Pharmac	S.F.

The details of some signatories are withheld. The relevant grounds under which information has been withheld are:

section 9(2)(a), to protect the privacy of individuals
section 9(2)(c), to protect the health or safety of members of the public
section 6(d), where making available of that information would likely endanger the safety of an individual

In regard to your request for ‘how many genetically female and how many genetically male signatories to Pfizer’s Covid-19 vaccine’ this information is not held by Pharmac and we do not have reason to believe that this information is held by another agency and therefore are declining this part of your request under OIA section 18(g).

In making our decision, we have considered the public interest considerations in section 9(1) of the Act. No public interest has been identified that would be sufficient to override the reasons for withholding that information.

We trust that this information answers your queries. Please note, you have the right to make a complaint to the Ombudsman about our response to your OIA, under section 28(3) of the OIA. Details of how to make a complaint(external link) are on the Ombudsman’s website.

To make information more freely available, we publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.